ITP - IMMUNE THROMBOCYTOPENIA
Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited cells take aim at incurable blood diseases
Disease control Not yet recruitingThis early-stage trial tests a new treatment called CTX112 for adults with two serious autoimmune blood diseases—immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA)—that have not responded to standard therapies. CTX112 uses CRISPR gene editing to create don…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
New combo therapy aims to boost platelets in immune disorder
Disease control Not yet recruitingThis study tests whether adding all-trans retinoic acid to avatrombopag works better than avatrombopag alone for adults with immune thrombocytopenia (ITP) who didn't improve with first treatment. About 248 participants will take the drugs for up to 24 weeks, then taper off, and b…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 15:59 UTC